Pan India Rollout Of Pneumococcal Conjugate Vaccine Will Reduce Child Mortality By 60 Percent: Health Minister
- byDoctor News Daily Team
- 29 July, 2025
- 0 Comments
- 0 Mins
New Delhi: Union Health Minister Mansukh Mandaviya on Friday said the nationwide rollout of Pneumococcal Conjugate Vaccine (PCV) will reduce the child mortality rate by 60 per cent.
Launching the PCV, under the Universal Immunisation Programme (UIP) as a part of Azadi ka Amrut Mahotsav, Mandaviya said pneumonia is a leading cause of death among children under 5 years, globally and in India.
Also Read:Pfizer gets USFDA priority review for 20-valent pneumococcal conjugate vaccine
"In India, around 16 per cent of deaths in children occur due to pneumonia. The nationwide rollout of PCV will reduce child mortality by around 60 per cent," he stated.
He also released communication and awareness packages on PCV to create widespread mass awareness. These communication packages will be shared with all States/UTs for further adaptation and utilisation.
Highlighting the importance of healthy children in any country's growth, productivity and development, Mandaviya said: "Children are the future of our country and it is our responsibility to provide them a healthy life. Mission Indradhanush which was launched by the Honourable Prime Minister is one such endeavour in this regard."
He said that Prime Minister Modi's vision of 'Sabko vaccine, muft vaccine' has ensured that the eligible population gets access to COVID-19 vaccines across the country.
While releasing the communication package for the vaccine, Mandaviya exhorted that creating awareness regarding the vaccine is a vital component. The objective of the vaccine is to save the lives of our children and this would be possible if we run a successful awareness campaign across the country.
Universal Immunization Programme (UIP) is one of the largest public health programmes targeting close to 26.7 million newborns and 29 million pregnant women annually.
Also Read:Panacea Biotec eyes to ramp up vaccine, pharma verticals to steer long-term growth
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:
Recent News
Only 31 percent families of doctors who died battl...
- 06 November, 2025
NEET 2025: MP DME releases mop up round allotment...
- 06 November, 2025
PG Medical Admissions 2025: CEE Kerala publishes f...
- 06 November, 2025
Venus Remedies expands presence in Vietnam with ma...
- 06 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!